THE TREATMENT OF SYPHILIS.
D002751:Chlortetracycline; D003140:Communicable Disease Control; D005029:Ethylenediamines; D006801:Humans; D008281:Maine; D009494:Neurosyphilis; D010118:Oxytetracycline; D010400:Penicillin G; D010401:Penicillin G Benzathine; D010402:Penicillin G Procaine; D010406:Penicillins / Q000009:adverse effects* / Q000633:toxicity*; D011343:Procaine; D013587:Syphilis; D013588:Syphilis Serodiagnosis; D013590:Syphilis, Congenital; D013592:Syphilis, Latent; D014116:Toxicology
D005029:Ethylenediamines; D010406:Penicillins; D010402:Penicillin G Procaine; D011343:Procaine; C010044:benzathine; D010400:Penicillin G; D010401:Penicillin G Benzathine; D002751:Chlortetracycline; D010118:Oxytetracycline
CHLORTETRACYCLINE; COMMUNICABLE DISEASE CONTROL; MAINE; NEUROSYPHILIS; OXYTETRACYCLINE; PENICILLIN G, BENZATHINE; PENICILLIN G, PROCAINE; PENICILLIN TOXICOLOGY; SYPHILIS; SYPHILIS SERODIAGNOSIS; SYPHILIS, CONGENITAL; SYPHILIS, LATENT; TOXICOLOGIC REPORT